Evaluation of Type A Botulinal Toxin Assays that Use Antitoxin to Crystalline Toxin

AUTOR(ES)

Sugiyama, H.

RESUMO

The type A botulinal toxin assay by the reverse passive hemagglutination procedure which uses antitoxin to crystalline toxin was examined for specificity. The analysis was based on the fact that crystalline type A toxin is a complex of neurotoxic protein (Aα) and a nontoxic protein (Aβ). By using these components, obtained in essentially pure forms, it was shown that the antitoxin to crystalline toxin has a significantly higher titer to Aβ than to Aα. When Formalin-treated red blood cells were sensitized with this antitoxin, the antibodies coupled to the cells were, for practical results, only anti-Aβ. When the suspension is reacted with dilutions of type A toxic solutions, the limiting dilutions are determined by Aβ and not by the neurotoxin, which should be the determinant if the assay is to measure toxicity. These observations may be pertinent to the development of serological assays for other botulinal toxin types.

Documentos Relacionados

• INFLUENCE OF INGESTED FOODS ON THE ORAL TOXICITY IN MICE OF CRYSTALLINE BOTULINAL TYPE A TOXIN1
• ACTIVITY OF TYPE A BOTULINAL TOXIN AND HEMAGGLUTININ EXPOSED TO PROTEOLYTIC ENZYME1
• Amino acid composition of crystalline botulinum toxin, type A.
• THE LACK OF IDENTITY BETWEEN HEMAGGLUTININ AND THE TOXIN OF TYPE A BOTULINAL ORGANISM
• Detection of Type E Botulinal Toxin in Cultures by Fluorescent-Antibody Microscopy